ClinicalTrials.gg
Not yet recruitingNCT07912749Updated Nov 5, 2026

End of Term vs. End of Module Examinations in the Preclinical Stage: A Cross-Sectional Survey of Student and Faculty Perspectives

An observational study in Student and Faculty Perspectives About Examinations, sponsored by New Valley University. Not yet recruiting. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-05.

Sponsored by New Valley University · Observational

Updated Nov 3, 2026Newly registeredGo to Updates ↓
Study type
Observational
Model
Cohort
Time perspective
Cross-sectional
Enrollment
1,000
Ages
18 Years and older
Sex
All
01

Study summary

Current practice and debate: Many medical schools use hybrid models that combine modular and final exams to balance reliability, validity, and feasibility. Still, there is no consensus on the optimal structure. The debate centers on three issues: educational impact, student stress, and faculty workload. Modular systems may support continuous learning but raise concerns about assessment burden and fragmentation of knowledge, as students may learn topics in isolation rather than as an integrated whole. End-of-term exams, by contrast, risk encouraging short-term memorization even though they test integration more effectively.

Justification for the study: Given these competing advantages and drawbacks, the study aims to explore the perspectives of both students and faculty on the two approaches. Understanding how each stakeholder group perceives the effects on learning, stress, workload, and performance can fill a gap in the existing literature, which focuses mainly on learning behaviors rather than stakeholder views.

Expected contribution: The findings are intended to inform evidence-based decisions on assessment design in preclinical medical education. By clarifying the trade-offs between distributed and cumulative exams, the study seeks to help institutions optimize learning outcomes while keeping assessment workload and student stress manageable

Read the detailed description

How do end-of-term versus end-of-module examinations influence student learning, performance, and stakeholder perceptions in pre-clinical medical education? Background Assessment is a cornerstone of medical education, shaping students' learning approaches, knowledge retention, and competency development. In the preclinical stage, summative assessments are commonly delivered either as end-of-term (comprehensive, high-stakes examinations) or as end-of-module (frequent, distributed assessments). The research question underpinning this study is Existing literature highlights that assessment strategies significantly affect learning behaviors. Modular assessments, conducted at shorter intervals, are associated with enhanced knowledge retention through the "testing effect" and promote continuous engagement with course material. In contrast, end-of-term examinations tend to encourage more intensive, often surface-level revision strategies due to their cumulative nature (1). Evidence also suggests that frequent modular assessments may foster deeper learning and personal development, whereas fewer high-stakes exams may increase stress and reduce opportunities for formative feedback (2).

Currently, many medical schools adopt hybrid strategies combining modular and final assessments to balance reliability, validity, and feasibility. However, there remains ongoing debate regarding the optimal structure, particularly in terms of educational impact, student stress, and faculty workload. While modular systems may enhance continuous learning, concerns persist regarding assessment burden and fragmentation of knowledge. Conversely, end-of-term exams may better evaluate integrative understanding but risk promoting short-term memorization.

Therefore, this study is justified by the need to explore both student and faculty perspectives on these contrasting approaches. Understanding these perceptions will help inform evidence-based assessment design and optimize learning outcomes in preclinical medical education.

02

Conditions studied

  • Student and Faculty Perspectives About Examinations
03

In context

Lead sponsor

New Valley University is the lead sponsor of 25 studies on the registry; 14 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

  • 2nd-year undergraduate medical students (who have experienced both systems) + faculty members involved in teaching and assessment in Years 1 and 2 (in the Faculty of Medicine, Assiut University)

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • 2nd-year undergraduate medical students (who have experienced both systems) + faculty members involved in teaching and assessment in Years 1 and 2 (in the Faculty of Medicine, Assiut University)

Exclusion criteria

Exclusion Criteria:

  • 1- The student or faculty members who refuse to participate in the study
05

Study design

Observational model
Cohort
Time perspective
Cross-sectional
Enrollment
1,000 participants (estimated)
Patient registry
No

Interventions

  • Othersurvey

    A structured Likert-scale questionnaire (5-point scale: Strongly Disagree → Strongly Agree) covering satisfaction, perceived fairness, academic stress, learning continuity, and effectiveness

06

What researchers measure

Primary outcomes

  1. To compare student and faculty satisfaction and perceived effectiveness between the vertical (end-of-term) examination system used in Year 1 and the horizontal (end-of-module) examination system used in Year 2 among undergraduate medical students

    A structured Likert-scale questionnaire (5-point scale: Strongly Disagree → Strongly Agree) covering satisfaction, perceived fairness, academic stress, learning continuity, and effectiveness by anonymous self-administered online or paper-based survey

    Time frame: 2-4 months

07

Study locations

No study locations are listed for this record.

08

Timeline

2 registry updates since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Dec 2026; primary completion for Mar 2027, 3 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 27, 2026
First posted
Nov 3, 2026
StartEst.
Dec 2026
Primary completionEst.
Mar 2027
CompletionEst.
May 2027
Last update
Nov 5, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 3, 2026
Show all 2 updates
  1. Nov 5, 2026
    Minor edits only
    + 2 other changes: verification date and conditions
  2. Nov 3, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

09

Registry details

Key details

Study ID
NCT07912749
Lead sponsor
New Valley University
Collaborators
Assiut University
Responsible party
Asmaa Kamel Ahmed Hassan (Lecturer -faculty of medicine -new valley university, New Valley University) — Principal investigator
First posted
Nov 3, 2026
Start date
Dec 2026 (estimated)
Primary completion
Mar 2027 (estimated)
Completion
May 2027 (estimated)
Last update
Nov 5, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion